$ESLA Balance Sheet | Understand Stock

$ESLA

$0.82 -$0.11 (11.86%) Close

$ESLA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Unaudited Condensed Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jul 19, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Current assets:
Cash and cash equivalents
Prepaid expenses and other receivables
Prepaid expenses, related party
Related Party
Total prepaid expenses, related party
Cash held in trust account
Total current assets
Total current assets
Investments held in Trust Account
Other Assets
Prepaid expenses, related party , non-current
Related Party
Total prepaid expenses, related party , non-current
Prepaid expenses, related party, non-current
Total Assets
Current liabilities:
Accounts payable and accrued expenses
Promissory notes
Working capital loans - related parties
Due to a related party
Accounts payable - related party
Stock redemption payable
Promissory note
Franchise tax payables
Income tax payables
Other payables and accrued liabilities
Accrued liability - related party
Related Party
Total accrued liability - related party
Derivative liabilities
Franchise tax payable
Income tax payable
Total current liabilities

Deferred tax liability
Deferred underwriters’ marketing fees
Total Liabilities
Common stock subject to possible redemption, 910,220 shares at redemption value of $10.71 and 10.25 per share as of June 30, 2023 and December 31, 2022, respectively
Stockholders’ Deficit:
Common stock, $0.0001 par value; 250,000,000 shares authorized; 43,549,509 and 38,486,219 shares issued as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Treasury stock, at cost 515,281 shares as of June 30, 2026 and December 31, 2025
Total Stockholders’ Deficit
Total Liabilities and Stockholders’ Deficit

Comments